Solar PV Operational

Merck - Upper Gwynedd Solar Array: 1.5 MW Solar PV Facility in Pennsylvania

United States of America
Visit official website

Overview

Merck - Upper Gwynedd Solar Array is a 1.5 MW solar PV facility in Pennsylvania, USA. It provides renewable energy to Merck's operations, supporting corporate sustainability goals.

Merck - Upper Gwynedd Solar Array is a 1.5 MW solar photovoltaic facility located in Upper Gwynedd, Pennsylvania, United States. The plant is owned by Merck and is operational, contributing to the company's renewable energy portfolio. As a small-scale solar installation, it aligns with typical corporate on-site generation projects in the region. The facility operates under the regulatory framework of the United States, which includes the Inflation Reduction Act (IRA) and state-level Renewable Portfolio Standards (RPS). Pennsylvania's RPS requires a percentage of electricity from renewable sources, supporting projects like this solar array. The plant uses solar PV technology, converting sunlight directly into electricity without emissions. Environmentally, the solar array reduces Merck's carbon footprint and reliance on grid electricity. It occupies a relatively small land area, minimizing visual and land-use impacts. The facility contributes to local renewable energy capacity and demonstrates corporate leadership in sustainability.

Environmental context

The solar array is located in a suburban area of Pennsylvania, where land use is primarily industrial and commercial. Solar PV installations have minimal environmental impact during operation, with no emissions or water use. The facility helps reduce greenhouse gas emissions and supports local renewable energy targets, though it requires careful siting to avoid habitat disruption.

Frequently asked questions

The facility is located in Upper Gwynedd, Pennsylvania, United States, at coordinates 40.2154, -75.2831.

The solar array has a capacity of 1.5 megawatts (MW), making it a small-scale solar PV installation.

The facility is owned by Merck, a global pharmaceutical company, as part of its renewable energy initiatives.

Solar PV in the US benefits from the Inflation Reduction Act (IRA) and state Renewable Portfolio Standards (RPS), which incentivize renewable energy deployment.

By generating clean electricity, the array reduces greenhouse gas emissions and supports Merck's sustainability targets, aligning with broader renewable energy adoption in Pennsylvania.
UtilityRadar
More
Press Esc to close · Browse by sector